• Home
• About Us
  • Team
  • Scientific Co-Founders and Advisors
  • Board of Directors
  • Investors
• Our Programs
  • Pipeline
  • VE202
  • VE303
  • VE707
• Clinical Trials
  • VE202 for Inflammatory Bowel Disease
  • VE303 for Recurrent C. difficile Infection
  • Expanded Access Policy
• Product Engine
  • Discovery
  • Manufacturing
  • Intellectual Property
  • Publications
• News & Media
  • Press Releases
  • In The News
• Careers
• Contact
• Privacy Policy
• Disclaimer
• Sitemap